2159 Stock Overview
An investment holding company, provides integrated healthcare marketing solutions in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Mediwelcome Healthcare Management & Technology Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.53 |
| 52 Week High | HK$0.68 |
| 52 Week Low | HK$0.30 |
| Beta | 0.35 |
| 1 Month Change | 39.47% |
| 3 Month Change | 51.43% |
| 1 Year Change | 27.71% |
| 3 Year Change | -60.15% |
| 5 Year Change | n/a |
| Change since IPO | -86.02% |
Recent News & Updates
Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Stock Catapults 41% Though Its Price And Business Still Lag The Industry
Dec 17
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues Despite A 25% Share Price Rise
Oct 03Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Jun 18Recent updates
Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Stock Catapults 41% Though Its Price And Business Still Lag The Industry
Dec 17There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues Despite A 25% Share Price Rise
Oct 03Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Jun 18Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet
Mar 06There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues
Aug 15Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively
Aug 12Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)
Apr 08Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital
Jan 24Shareholder Returns
| 2159 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 51.4% | -1.3% | -0.5% |
| 1Y | 27.7% | -17.8% | 19.9% |
Return vs Industry: 2159 exceeded the Hong Kong Healthcare industry which returned -17.8% over the past year.
Return vs Market: 2159 exceeded the Hong Kong Market which returned 19.9% over the past year.
Price Volatility
| 2159 volatility | |
|---|---|
| 2159 Average Weekly Movement | 11.1% |
| Healthcare Industry Average Movement | 8.3% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 2159 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2159's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 280 | Liang Wang | www.mediwelcome.com |
Mediwelcome Healthcare Management & Technology Inc., an investment holding company, provides integrated healthcare marketing solutions in the People’s Republic of China. The company offers academic sonference management system, a digital management system for medical conference; scientific data reporting system, a technical service of single disease clinical research data collection; and health education media, a health science cloud platform, patient care center, patient management center, and health education media. It also provides medical conference, patient education and screening, and marketing strategy and consulting services; digital marketing and sales solutions services; contract research organization services; and internet hospital services.
Mediwelcome Healthcare Management & Technology Inc. Fundamentals Summary
| 2159 fundamental statistics | |
|---|---|
| Market cap | HK$106.00m |
| Earnings (TTM) | -HK$86.00m |
| Revenue (TTM) | HK$346.42m |
0.3x
P/S Ratio-1.2x
P/E RatioIs 2159 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2159 income statement (TTM) | |
|---|---|
| Revenue | CN¥325.06m |
| Cost of Revenue | CN¥293.38m |
| Gross Profit | CN¥31.67m |
| Other Expenses | CN¥112.37m |
| Earnings | -CN¥80.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.40 |
| Gross Margin | 9.74% |
| Net Profit Margin | -24.83% |
| Debt/Equity Ratio | 21.3% |
How did 2159 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:50 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mediwelcome Healthcare Management & Technology Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|